Vimarsana
Biggest News Aggregation in the World

Page 9 - Oral Solution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oral Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oral Solution Today - Breaking & Trending Today

Nippon Shinyaku : UCB Japan Obtained Additional Application of Fintepla® (fenfluramine) for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome in Japan -March 26, 2024 at 03:06 am EDT - Vimarsana News

Nippon Shinyaku : UCB Japan Obtained Additional Application of Fintepla® (fenfluramine) for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome in Japan -March 26, 2024 at 03:06 am EDT

NEWS RELEASE March 26, 2024 UCB Japan Obtained Additional Application of Fintepla® for the Treatment of Seizures...

MIKART ANNOUNCES VALIDATION OF ITS NEW LIQUID AND SUSPENSION SUITE - Vimarsana News

MIKART ANNOUNCES VALIDATION OF ITS NEW LIQUID AND SUSPENSION SUITE

/PRNewswire/ -- Mikart LLC, a leading contract development and manufacturing company, proudly announces the successful validation of its liquid product within...

Codeine cough syrup abuse prompts ban on UK sales - Vimarsana News

Codeine cough syrup abuse prompts ban on UK sales

The medicine will only be available with a prescription because of rising reports of misuse.

Source: bbc.co.uk
[Latest] Global Medical Implant Market Size/Share Worth USD - Vimarsana News

[Latest] Global Medical Implant Market Size/Share Worth USD

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Medical Implant Market...

Panacea Biotec shares trade flat after USFDA classifies Baddi facility as OAI - Vimarsana News

Panacea Biotec shares trade flat after USFDA classifies Baddi facility as OAI

A meeting of the board of directors of the company is scheduled to be held on February 13 to consider and approve the unaudited financial results.